- $15.07m
- -$12.10m
- 20
- 47
- 38
- 27
Annual income statement for Galecto, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 39 | 33.6 | 52.2 | 61.2 | 39.9 |
Operating Profit | -39 | -33.6 | -52.2 | -61.2 | -39.9 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -36.5 | -34.8 | -51.8 | -61.6 | -38.3 |
Net Income After Taxes | -36.5 | -34.8 | -51.8 | -61.6 | -38.3 |
Net Income Before Extraordinary Items | |||||
Net Income | -36.5 | -34.8 | -51.8 | -61.6 | -38.3 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -42.1 | -34.8 | -51.8 | -61.6 | -38.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.03 | -1.38 | -2.05 | -2.43 | -1.32 |
Dividends per Share |